Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syed Hissar

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|October 6, 2025
Impact of cytomegalovirus exposure on disease severity, bacterial burden, immune responses and treatment outcomes in tuberculosisBindu Dasan, Saravanan Munisankar, Nathella Pavan Kumar, et al.
Tuberculosis (Edinburgh, Scotland)|October 17, 2022
Comparison of two mycobacterial strains in performance of the whole blood mycobacterial growth inhibition assay in Indian childrenAishwarya Venkataraman, Sivakumar Shanmugam, Sarath Balaji, et al.
BMC Infectious Diseases|November 27, 2020
The recent trend in mycobacterial strain diversity among extra pulmonary lymph node tuberculosis and their association with drug resistance and the host immunological response in South IndiaShanmugam Sivakumar, Yuvaraj Chandramohan, Gokul Raj Kathamuthu, et al.
Scientific Reports|January 16, 2023
Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severityPavithra Sampath, Anuradha Rajamanickam, Kannan Thiruvengadam, et al.
Scientific Reports|May 6, 2023
Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosisPavithra Sampath, Anuradha Rajamanickam, Kannan Thiruvengadam, et al.
Frontiers in Immunology|June 18, 2024
Distinct TB-antigen stimulated cytokine profiles as predictive biomarkers for unfavorable treatment outcomes in pulmonary tuberculosisArul Nancy Pandiarajan, Nathella Pavan Kumar, Nandhini Selvaraj, et al.
Frontiers in Immunology|August 1, 2022
Differential Frequencies of Intermediate Monocyte Subsets Among Individuals Infected With Drug-Sensitive or Drug-Resistant <i>Mycobacterium tuberculosis</i>Pavithra Sampath, Alangudi Palaniappan Natarajan, Kadar Moideen, et al.
The Journal of Infectious Diseases|August 6, 2022
Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen-Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After RecoveryNathella Pavan Kumar, Aishwarya Venkataraman, Arul Nancy, et al.
Frontiers in Immunology|May 15, 2025
Acute-phase proteins as biomarkers of inflammation in HIV patients with latent tuberculosis: a prospective studyNathella Pavan Kumar, Rajamariyam M, Arul Nancy, et al.
Diseases (Basel, Switzerland)|June 25, 2025
Plasma Matrix Metalloproteinases Signature as Biomarkers for Pediatric Tuberculosis Diagnosis: A Prospective Case-Control StudyNathella Pavan Kumar, Syed Hissar, Arul Nancy, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|October 6, 2025
Impact of cytomegalovirus exposure on disease severity, bacterial burden, immune responses and treatment outcomes in tuberculosisBindu Dasan, Saravanan Munisankar, Nathella Pavan Kumar, et al.
Tuberculosis (Edinburgh, Scotland)|October 17, 2022
Comparison of two mycobacterial strains in performance of the whole blood mycobacterial growth inhibition assay in Indian childrenAishwarya Venkataraman, Sivakumar Shanmugam, Sarath Balaji, et al.
BMC Infectious Diseases|November 27, 2020
The recent trend in mycobacterial strain diversity among extra pulmonary lymph node tuberculosis and their association with drug resistance and the host immunological response in South IndiaShanmugam Sivakumar, Yuvaraj Chandramohan, Gokul Raj Kathamuthu, et al.
Scientific Reports|January 16, 2023
Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severityPavithra Sampath, Anuradha Rajamanickam, Kannan Thiruvengadam, et al.
Scientific Reports|May 6, 2023
Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosisPavithra Sampath, Anuradha Rajamanickam, Kannan Thiruvengadam, et al.
Frontiers in Immunology|June 18, 2024
Distinct TB-antigen stimulated cytokine profiles as predictive biomarkers for unfavorable treatment outcomes in pulmonary tuberculosisArul Nancy Pandiarajan, Nathella Pavan Kumar, Nandhini Selvaraj, et al.
Frontiers in Immunology|August 1, 2022
Differential Frequencies of Intermediate Monocyte Subsets Among Individuals Infected With Drug-Sensitive or Drug-Resistant <i>Mycobacterium tuberculosis</i>Pavithra Sampath, Alangudi Palaniappan Natarajan, Kadar Moideen, et al.
The Journal of Infectious Diseases|August 6, 2022
Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen-Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After RecoveryNathella Pavan Kumar, Aishwarya Venkataraman, Arul Nancy, et al.
Frontiers in Immunology|May 15, 2025
Acute-phase proteins as biomarkers of inflammation in HIV patients with latent tuberculosis: a prospective studyNathella Pavan Kumar, Rajamariyam M, Arul Nancy, et al.
Diseases (Basel, Switzerland)|June 25, 2025
Plasma Matrix Metalloproteinases Signature as Biomarkers for Pediatric Tuberculosis Diagnosis: A Prospective Case-Control StudyNathella Pavan Kumar, Syed Hissar, Arul Nancy, et al.
Pageof 7